HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men.

Abstract
Hypogonadism commonly occurs during withdrawal from anabolic-androgenic steroid (AAS) use, particularly when users have been taking AAS for prolonged periods. Mounting evidence now suggests that AAS-induced hypogonadism may persist for months or even years after last AAS use, and in some cases may be partially or completely irreversible. Treatment with human chorionic gonadotropin and clomiphene may help to restore hypothalamic-pituitary-testicular axis function, and these substances are widely used illicitly by AAS users at the end of a course of AAS as so-called postcycle therapy. Many endocrinologists still have only limited experience in diagnosing and treating AAS-induced hypogonadism.
AuthorsHarrison G Pope Jr, Gen Kanayama
JournalEndocrinology and metabolism clinics of North America (Endocrinol Metab Clin North Am) Vol. 51 Issue 1 Pg. 205-216 (03 2022) ISSN: 1558-4410 [Electronic] United States
PMID35216717 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2021 Elsevier Inc. All rights reserved.
Chemical References
  • Anabolic Agents
  • Testosterone Congeners
Topics
  • Anabolic Agents (adverse effects)
  • Body Dysmorphic Disorders
  • Humans
  • Hypogonadism (chemically induced, diagnosis, drug therapy)
  • Male
  • Substance-Related Disorders
  • Testis
  • Testosterone Congeners (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: